Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
- Publikationsjahr: 2021
- Titel: Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
- Autoren: Neubauer, A.;Johow, J.;Mack, E.;Burchert, A.;Meyn, D.;Kadlubiec, A.;Torje, I.;Wulf, H.;Vogelmeier, C. F.;Hoyer, J.;Skevaki, C.;Muellenbach, R. M.;Keller, C.;Schade-Brittinger, C.;Rolfes, C.;Wiesmann, T.
- Journal: Leukemia
- DOI: 10.1038/s41375-021-01412-0